Research ArticleArticle
Can Serum Surfactant Protein D or CC-Chemokine Ligand 18 Predict Outcome of Interstitial Lung Disease in Patients with Early Systemic Sclerosis?
Mona Elhaj, Julio Charles, Claudia Pedroza, Xiaochun Liu, Xiaodong Zhou, Rosa M. Estrada-Y-Martin, Emilio B. Gonzalez, Dorothy E. Lewis, Hilda T. Draeger, Sarah Kim, Frank C. Arnett, Maureen D. Mayes and Shervin Assassi
The Journal of Rheumatology April 2013, jrheum.120997; DOI: https://doi.org/10.3899/jrheum.120997
Mona Elhaj
From the University of Texas Health Science Center at Houston, Houston; University of Texas Medical Branch at Galveston, Galveston; and the University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA. Supported by the US National Institutes of Health (NIH)/US National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) P50 AR054144 (Dr. Mayes); NIH/NIAMS K23 AR061436 (Dr. Assassi); NIH N01 AR2251, R01 AR055258 (Dr. Mayes); NIH 1U01AI09090-01 (Dr. Zhou, Dr. Mayes); NIH T32 AR052283 (Reveille); University Clinic Research Center Grants M01 RR00073 (UTMB) and M01 RR01346 (UTHSC-SA); and NIH Clinical and Translational Sciences Award UL1 RR024148 and TL1 RR024147 from the National Center for Research Resources. M. Elhaj, MD; J. Charles, MS; C. Pedroza, PhD; X. Liu, MD, PhD; X. Zhou, MD; R.M. Estrada-Y-Martin, MD, MS, University of Texas Health Science Center at Houston; E.B. Gonzalez, MD, University of Texas Medical Branch at Galveston; D.E. Lewis, PhD, University of Texas Health Science Center at Houston; H.T. Draeger, MD, University of Texas Health Science Center at San Antonio; S. Kim, BS; F.C. Arnett, MD; M.D. Mayes, MD, MPH; S. Assassi, MD, MS, University of Texas Health Science Center at Houston. Address correspondence to Dr. S. Assassi, University of Texas Health Science Center at Houston, 6431 Fannin Street, MSB 5.266, Houston, TX 77030, USA. E-mail: shervin.assassi@uth.tmc.edu. Accepted for publication January 31, 2013.
Julio Charles
From the University of Texas Health Science Center at Houston, Houston; University of Texas Medical Branch at Galveston, Galveston; and the University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA. Supported by the US National Institutes of Health (NIH)/US National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) P50 AR054144 (Dr. Mayes); NIH/NIAMS K23 AR061436 (Dr. Assassi); NIH N01 AR2251, R01 AR055258 (Dr. Mayes); NIH 1U01AI09090-01 (Dr. Zhou, Dr. Mayes); NIH T32 AR052283 (Reveille); University Clinic Research Center Grants M01 RR00073 (UTMB) and M01 RR01346 (UTHSC-SA); and NIH Clinical and Translational Sciences Award UL1 RR024148 and TL1 RR024147 from the National Center for Research Resources. M. Elhaj, MD; J. Charles, MS; C. Pedroza, PhD; X. Liu, MD, PhD; X. Zhou, MD; R.M. Estrada-Y-Martin, MD, MS, University of Texas Health Science Center at Houston; E.B. Gonzalez, MD, University of Texas Medical Branch at Galveston; D.E. Lewis, PhD, University of Texas Health Science Center at Houston; H.T. Draeger, MD, University of Texas Health Science Center at San Antonio; S. Kim, BS; F.C. Arnett, MD; M.D. Mayes, MD, MPH; S. Assassi, MD, MS, University of Texas Health Science Center at Houston. Address correspondence to Dr. S. Assassi, University of Texas Health Science Center at Houston, 6431 Fannin Street, MSB 5.266, Houston, TX 77030, USA. E-mail: shervin.assassi@uth.tmc.edu. Accepted for publication January 31, 2013.
Claudia Pedroza
From the University of Texas Health Science Center at Houston, Houston; University of Texas Medical Branch at Galveston, Galveston; and the University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA. Supported by the US National Institutes of Health (NIH)/US National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) P50 AR054144 (Dr. Mayes); NIH/NIAMS K23 AR061436 (Dr. Assassi); NIH N01 AR2251, R01 AR055258 (Dr. Mayes); NIH 1U01AI09090-01 (Dr. Zhou, Dr. Mayes); NIH T32 AR052283 (Reveille); University Clinic Research Center Grants M01 RR00073 (UTMB) and M01 RR01346 (UTHSC-SA); and NIH Clinical and Translational Sciences Award UL1 RR024148 and TL1 RR024147 from the National Center for Research Resources. M. Elhaj, MD; J. Charles, MS; C. Pedroza, PhD; X. Liu, MD, PhD; X. Zhou, MD; R.M. Estrada-Y-Martin, MD, MS, University of Texas Health Science Center at Houston; E.B. Gonzalez, MD, University of Texas Medical Branch at Galveston; D.E. Lewis, PhD, University of Texas Health Science Center at Houston; H.T. Draeger, MD, University of Texas Health Science Center at San Antonio; S. Kim, BS; F.C. Arnett, MD; M.D. Mayes, MD, MPH; S. Assassi, MD, MS, University of Texas Health Science Center at Houston. Address correspondence to Dr. S. Assassi, University of Texas Health Science Center at Houston, 6431 Fannin Street, MSB 5.266, Houston, TX 77030, USA. E-mail: shervin.assassi@uth.tmc.edu. Accepted for publication January 31, 2013.
Xiaochun Liu
From the University of Texas Health Science Center at Houston, Houston; University of Texas Medical Branch at Galveston, Galveston; and the University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA. Supported by the US National Institutes of Health (NIH)/US National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) P50 AR054144 (Dr. Mayes); NIH/NIAMS K23 AR061436 (Dr. Assassi); NIH N01 AR2251, R01 AR055258 (Dr. Mayes); NIH 1U01AI09090-01 (Dr. Zhou, Dr. Mayes); NIH T32 AR052283 (Reveille); University Clinic Research Center Grants M01 RR00073 (UTMB) and M01 RR01346 (UTHSC-SA); and NIH Clinical and Translational Sciences Award UL1 RR024148 and TL1 RR024147 from the National Center for Research Resources. M. Elhaj, MD; J. Charles, MS; C. Pedroza, PhD; X. Liu, MD, PhD; X. Zhou, MD; R.M. Estrada-Y-Martin, MD, MS, University of Texas Health Science Center at Houston; E.B. Gonzalez, MD, University of Texas Medical Branch at Galveston; D.E. Lewis, PhD, University of Texas Health Science Center at Houston; H.T. Draeger, MD, University of Texas Health Science Center at San Antonio; S. Kim, BS; F.C. Arnett, MD; M.D. Mayes, MD, MPH; S. Assassi, MD, MS, University of Texas Health Science Center at Houston. Address correspondence to Dr. S. Assassi, University of Texas Health Science Center at Houston, 6431 Fannin Street, MSB 5.266, Houston, TX 77030, USA. E-mail: shervin.assassi@uth.tmc.edu. Accepted for publication January 31, 2013.
Xiaodong Zhou
From the University of Texas Health Science Center at Houston, Houston; University of Texas Medical Branch at Galveston, Galveston; and the University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA. Supported by the US National Institutes of Health (NIH)/US National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) P50 AR054144 (Dr. Mayes); NIH/NIAMS K23 AR061436 (Dr. Assassi); NIH N01 AR2251, R01 AR055258 (Dr. Mayes); NIH 1U01AI09090-01 (Dr. Zhou, Dr. Mayes); NIH T32 AR052283 (Reveille); University Clinic Research Center Grants M01 RR00073 (UTMB) and M01 RR01346 (UTHSC-SA); and NIH Clinical and Translational Sciences Award UL1 RR024148 and TL1 RR024147 from the National Center for Research Resources. M. Elhaj, MD; J. Charles, MS; C. Pedroza, PhD; X. Liu, MD, PhD; X. Zhou, MD; R.M. Estrada-Y-Martin, MD, MS, University of Texas Health Science Center at Houston; E.B. Gonzalez, MD, University of Texas Medical Branch at Galveston; D.E. Lewis, PhD, University of Texas Health Science Center at Houston; H.T. Draeger, MD, University of Texas Health Science Center at San Antonio; S. Kim, BS; F.C. Arnett, MD; M.D. Mayes, MD, MPH; S. Assassi, MD, MS, University of Texas Health Science Center at Houston. Address correspondence to Dr. S. Assassi, University of Texas Health Science Center at Houston, 6431 Fannin Street, MSB 5.266, Houston, TX 77030, USA. E-mail: shervin.assassi@uth.tmc.edu. Accepted for publication January 31, 2013.
Rosa M. Estrada-Y-Martin
From the University of Texas Health Science Center at Houston, Houston; University of Texas Medical Branch at Galveston, Galveston; and the University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA. Supported by the US National Institutes of Health (NIH)/US National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) P50 AR054144 (Dr. Mayes); NIH/NIAMS K23 AR061436 (Dr. Assassi); NIH N01 AR2251, R01 AR055258 (Dr. Mayes); NIH 1U01AI09090-01 (Dr. Zhou, Dr. Mayes); NIH T32 AR052283 (Reveille); University Clinic Research Center Grants M01 RR00073 (UTMB) and M01 RR01346 (UTHSC-SA); and NIH Clinical and Translational Sciences Award UL1 RR024148 and TL1 RR024147 from the National Center for Research Resources. M. Elhaj, MD; J. Charles, MS; C. Pedroza, PhD; X. Liu, MD, PhD; X. Zhou, MD; R.M. Estrada-Y-Martin, MD, MS, University of Texas Health Science Center at Houston; E.B. Gonzalez, MD, University of Texas Medical Branch at Galveston; D.E. Lewis, PhD, University of Texas Health Science Center at Houston; H.T. Draeger, MD, University of Texas Health Science Center at San Antonio; S. Kim, BS; F.C. Arnett, MD; M.D. Mayes, MD, MPH; S. Assassi, MD, MS, University of Texas Health Science Center at Houston. Address correspondence to Dr. S. Assassi, University of Texas Health Science Center at Houston, 6431 Fannin Street, MSB 5.266, Houston, TX 77030, USA. E-mail: shervin.assassi@uth.tmc.edu. Accepted for publication January 31, 2013.
Emilio B. Gonzalez
From the University of Texas Health Science Center at Houston, Houston; University of Texas Medical Branch at Galveston, Galveston; and the University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA. Supported by the US National Institutes of Health (NIH)/US National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) P50 AR054144 (Dr. Mayes); NIH/NIAMS K23 AR061436 (Dr. Assassi); NIH N01 AR2251, R01 AR055258 (Dr. Mayes); NIH 1U01AI09090-01 (Dr. Zhou, Dr. Mayes); NIH T32 AR052283 (Reveille); University Clinic Research Center Grants M01 RR00073 (UTMB) and M01 RR01346 (UTHSC-SA); and NIH Clinical and Translational Sciences Award UL1 RR024148 and TL1 RR024147 from the National Center for Research Resources. M. Elhaj, MD; J. Charles, MS; C. Pedroza, PhD; X. Liu, MD, PhD; X. Zhou, MD; R.M. Estrada-Y-Martin, MD, MS, University of Texas Health Science Center at Houston; E.B. Gonzalez, MD, University of Texas Medical Branch at Galveston; D.E. Lewis, PhD, University of Texas Health Science Center at Houston; H.T. Draeger, MD, University of Texas Health Science Center at San Antonio; S. Kim, BS; F.C. Arnett, MD; M.D. Mayes, MD, MPH; S. Assassi, MD, MS, University of Texas Health Science Center at Houston. Address correspondence to Dr. S. Assassi, University of Texas Health Science Center at Houston, 6431 Fannin Street, MSB 5.266, Houston, TX 77030, USA. E-mail: shervin.assassi@uth.tmc.edu. Accepted for publication January 31, 2013.
Dorothy E. Lewis
From the University of Texas Health Science Center at Houston, Houston; University of Texas Medical Branch at Galveston, Galveston; and the University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA. Supported by the US National Institutes of Health (NIH)/US National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) P50 AR054144 (Dr. Mayes); NIH/NIAMS K23 AR061436 (Dr. Assassi); NIH N01 AR2251, R01 AR055258 (Dr. Mayes); NIH 1U01AI09090-01 (Dr. Zhou, Dr. Mayes); NIH T32 AR052283 (Reveille); University Clinic Research Center Grants M01 RR00073 (UTMB) and M01 RR01346 (UTHSC-SA); and NIH Clinical and Translational Sciences Award UL1 RR024148 and TL1 RR024147 from the National Center for Research Resources. M. Elhaj, MD; J. Charles, MS; C. Pedroza, PhD; X. Liu, MD, PhD; X. Zhou, MD; R.M. Estrada-Y-Martin, MD, MS, University of Texas Health Science Center at Houston; E.B. Gonzalez, MD, University of Texas Medical Branch at Galveston; D.E. Lewis, PhD, University of Texas Health Science Center at Houston; H.T. Draeger, MD, University of Texas Health Science Center at San Antonio; S. Kim, BS; F.C. Arnett, MD; M.D. Mayes, MD, MPH; S. Assassi, MD, MS, University of Texas Health Science Center at Houston. Address correspondence to Dr. S. Assassi, University of Texas Health Science Center at Houston, 6431 Fannin Street, MSB 5.266, Houston, TX 77030, USA. E-mail: shervin.assassi@uth.tmc.edu. Accepted for publication January 31, 2013.
Hilda T. Draeger
From the University of Texas Health Science Center at Houston, Houston; University of Texas Medical Branch at Galveston, Galveston; and the University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA. Supported by the US National Institutes of Health (NIH)/US National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) P50 AR054144 (Dr. Mayes); NIH/NIAMS K23 AR061436 (Dr. Assassi); NIH N01 AR2251, R01 AR055258 (Dr. Mayes); NIH 1U01AI09090-01 (Dr. Zhou, Dr. Mayes); NIH T32 AR052283 (Reveille); University Clinic Research Center Grants M01 RR00073 (UTMB) and M01 RR01346 (UTHSC-SA); and NIH Clinical and Translational Sciences Award UL1 RR024148 and TL1 RR024147 from the National Center for Research Resources. M. Elhaj, MD; J. Charles, MS; C. Pedroza, PhD; X. Liu, MD, PhD; X. Zhou, MD; R.M. Estrada-Y-Martin, MD, MS, University of Texas Health Science Center at Houston; E.B. Gonzalez, MD, University of Texas Medical Branch at Galveston; D.E. Lewis, PhD, University of Texas Health Science Center at Houston; H.T. Draeger, MD, University of Texas Health Science Center at San Antonio; S. Kim, BS; F.C. Arnett, MD; M.D. Mayes, MD, MPH; S. Assassi, MD, MS, University of Texas Health Science Center at Houston. Address correspondence to Dr. S. Assassi, University of Texas Health Science Center at Houston, 6431 Fannin Street, MSB 5.266, Houston, TX 77030, USA. E-mail: shervin.assassi@uth.tmc.edu. Accepted for publication January 31, 2013.
Sarah Kim
From the University of Texas Health Science Center at Houston, Houston; University of Texas Medical Branch at Galveston, Galveston; and the University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA. Supported by the US National Institutes of Health (NIH)/US National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) P50 AR054144 (Dr. Mayes); NIH/NIAMS K23 AR061436 (Dr. Assassi); NIH N01 AR2251, R01 AR055258 (Dr. Mayes); NIH 1U01AI09090-01 (Dr. Zhou, Dr. Mayes); NIH T32 AR052283 (Reveille); University Clinic Research Center Grants M01 RR00073 (UTMB) and M01 RR01346 (UTHSC-SA); and NIH Clinical and Translational Sciences Award UL1 RR024148 and TL1 RR024147 from the National Center for Research Resources. M. Elhaj, MD; J. Charles, MS; C. Pedroza, PhD; X. Liu, MD, PhD; X. Zhou, MD; R.M. Estrada-Y-Martin, MD, MS, University of Texas Health Science Center at Houston; E.B. Gonzalez, MD, University of Texas Medical Branch at Galveston; D.E. Lewis, PhD, University of Texas Health Science Center at Houston; H.T. Draeger, MD, University of Texas Health Science Center at San Antonio; S. Kim, BS; F.C. Arnett, MD; M.D. Mayes, MD, MPH; S. Assassi, MD, MS, University of Texas Health Science Center at Houston. Address correspondence to Dr. S. Assassi, University of Texas Health Science Center at Houston, 6431 Fannin Street, MSB 5.266, Houston, TX 77030, USA. E-mail: shervin.assassi@uth.tmc.edu. Accepted for publication January 31, 2013.
Frank C. Arnett
From the University of Texas Health Science Center at Houston, Houston; University of Texas Medical Branch at Galveston, Galveston; and the University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA. Supported by the US National Institutes of Health (NIH)/US National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) P50 AR054144 (Dr. Mayes); NIH/NIAMS K23 AR061436 (Dr. Assassi); NIH N01 AR2251, R01 AR055258 (Dr. Mayes); NIH 1U01AI09090-01 (Dr. Zhou, Dr. Mayes); NIH T32 AR052283 (Reveille); University Clinic Research Center Grants M01 RR00073 (UTMB) and M01 RR01346 (UTHSC-SA); and NIH Clinical and Translational Sciences Award UL1 RR024148 and TL1 RR024147 from the National Center for Research Resources. M. Elhaj, MD; J. Charles, MS; C. Pedroza, PhD; X. Liu, MD, PhD; X. Zhou, MD; R.M. Estrada-Y-Martin, MD, MS, University of Texas Health Science Center at Houston; E.B. Gonzalez, MD, University of Texas Medical Branch at Galveston; D.E. Lewis, PhD, University of Texas Health Science Center at Houston; H.T. Draeger, MD, University of Texas Health Science Center at San Antonio; S. Kim, BS; F.C. Arnett, MD; M.D. Mayes, MD, MPH; S. Assassi, MD, MS, University of Texas Health Science Center at Houston. Address correspondence to Dr. S. Assassi, University of Texas Health Science Center at Houston, 6431 Fannin Street, MSB 5.266, Houston, TX 77030, USA. E-mail: shervin.assassi@uth.tmc.edu. Accepted for publication January 31, 2013.
Maureen D. Mayes
From the University of Texas Health Science Center at Houston, Houston; University of Texas Medical Branch at Galveston, Galveston; and the University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA. Supported by the US National Institutes of Health (NIH)/US National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) P50 AR054144 (Dr. Mayes); NIH/NIAMS K23 AR061436 (Dr. Assassi); NIH N01 AR2251, R01 AR055258 (Dr. Mayes); NIH 1U01AI09090-01 (Dr. Zhou, Dr. Mayes); NIH T32 AR052283 (Reveille); University Clinic Research Center Grants M01 RR00073 (UTMB) and M01 RR01346 (UTHSC-SA); and NIH Clinical and Translational Sciences Award UL1 RR024148 and TL1 RR024147 from the National Center for Research Resources. M. Elhaj, MD; J. Charles, MS; C. Pedroza, PhD; X. Liu, MD, PhD; X. Zhou, MD; R.M. Estrada-Y-Martin, MD, MS, University of Texas Health Science Center at Houston; E.B. Gonzalez, MD, University of Texas Medical Branch at Galveston; D.E. Lewis, PhD, University of Texas Health Science Center at Houston; H.T. Draeger, MD, University of Texas Health Science Center at San Antonio; S. Kim, BS; F.C. Arnett, MD; M.D. Mayes, MD, MPH; S. Assassi, MD, MS, University of Texas Health Science Center at Houston. Address correspondence to Dr. S. Assassi, University of Texas Health Science Center at Houston, 6431 Fannin Street, MSB 5.266, Houston, TX 77030, USA. E-mail: shervin.assassi@uth.tmc.edu. Accepted for publication January 31, 2013.
Shervin Assassi
From the University of Texas Health Science Center at Houston, Houston; University of Texas Medical Branch at Galveston, Galveston; and the University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA. Supported by the US National Institutes of Health (NIH)/US National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) P50 AR054144 (Dr. Mayes); NIH/NIAMS K23 AR061436 (Dr. Assassi); NIH N01 AR2251, R01 AR055258 (Dr. Mayes); NIH 1U01AI09090-01 (Dr. Zhou, Dr. Mayes); NIH T32 AR052283 (Reveille); University Clinic Research Center Grants M01 RR00073 (UTMB) and M01 RR01346 (UTHSC-SA); and NIH Clinical and Translational Sciences Award UL1 RR024148 and TL1 RR024147 from the National Center for Research Resources. M. Elhaj, MD; J. Charles, MS; C. Pedroza, PhD; X. Liu, MD, PhD; X. Zhou, MD; R.M. Estrada-Y-Martin, MD, MS, University of Texas Health Science Center at Houston; E.B. Gonzalez, MD, University of Texas Medical Branch at Galveston; D.E. Lewis, PhD, University of Texas Health Science Center at Houston; H.T. Draeger, MD, University of Texas Health Science Center at San Antonio; S. Kim, BS; F.C. Arnett, MD; M.D. Mayes, MD, MPH; S. Assassi, MD, MS, University of Texas Health Science Center at Houston. Address correspondence to Dr. S. Assassi, University of Texas Health Science Center at Houston, 6431 Fannin Street, MSB 5.266, Houston, TX 77030, USA. E-mail: shervin.assassi@uth.tmc.edu. Accepted for publication January 31, 2013.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Can Serum Surfactant Protein D or CC-Chemokine Ligand 18 Predict Outcome of Interstitial Lung Disease in Patients with Early Systemic Sclerosis?
Mona Elhaj, Julio Charles, Claudia Pedroza, Xiaochun Liu, Xiaodong Zhou, Rosa M. Estrada-Y-Martin, Emilio B. Gonzalez, Dorothy E. Lewis, Hilda T. Draeger, Sarah Kim, Frank C. Arnett, Maureen D. Mayes, Shervin Assassi
The Journal of Rheumatology Apr 2013, jrheum.120997; DOI: 10.3899/jrheum.120997
Can Serum Surfactant Protein D or CC-Chemokine Ligand 18 Predict Outcome of Interstitial Lung Disease in Patients with Early Systemic Sclerosis?
Mona Elhaj, Julio Charles, Claudia Pedroza, Xiaochun Liu, Xiaodong Zhou, Rosa M. Estrada-Y-Martin, Emilio B. Gonzalez, Dorothy E. Lewis, Hilda T. Draeger, Sarah Kim, Frank C. Arnett, Maureen D. Mayes, Shervin Assassi
The Journal of Rheumatology Apr 2013, jrheum.120997; DOI: 10.3899/jrheum.120997